This website will be unavailable from Friday, April 26, 2024 at 6:00 p.m. through Monday, April 29, 2024 at 7:00 a.m. due to data center maintenance.

  81R2891 ALB-D
 
  By: Gutierrez H.B. No. 1362
 
 
 
A BILL TO BE ENTITLED
 
AN ACT
  relating to the reporting of methicillin-resistant Staphylococcus
  aureus.
         BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
         SECTION 1.  Section 81.0445, Health and Safety Code, is
  amended to read as follows:
         Sec. 81.0445.  MRSA REPORTING PROCEDURES [PILOT] PROGRAM.  
  (a)  The executive commissioner of the Health and Human Services
  Commission by rule shall develop and the department shall establish
  a [pilot] program to research and implement procedures for
  reporting cases of methicillin-resistant Staphylococcus aureus
  (MRSA).  A health authority shall not be required to participate in
  the program.
         (b)  A health authority that participates in the program
  shall administer the program locally and report to the department
  as required by this section.  [The department shall select to
  administer the program a health authority that:
               [(1)     demonstrates an interest in hosting the program;
  and
               [(2)     possesses adequate resources to administer the
  program successfully.]
         (c)  The [pilot] program must:
               (1)  require all clinical laboratories, including
  hospital laboratories and clinical reference laboratories, within
  the area served by each [the] health authority participating in the
  program to report all positive cases of methicillin-resistant
  Staphylococcus aureus to the health authority [pilot] program
  administrator using automated and secure electronic data
  transmission;
               (2)  track the prevalence of methicillin-resistant
  Staphylococcus aureus;
               (3)  evaluate, on a biennial basis, [study] the cost
  and feasibility of expanding the list of reportable diseases
  established under this chapter to include methicillin-resistant
  Staphylococcus aureus;
               (4)  develop a methodology for the electronic exchange
  of information regarding the occurrence of methicillin-resistant
  Staphylococcus aureus within the area served by each [the] health
  authority participating in the program;
               (5)  collect data and analyze findings regarding the
  prevalence [sources and possible prevention] of
  methicillin-resistant Staphylococcus aureus;
               (6)  provide for the reporting to the public by the
  department of information regarding methicillin-resistant
  Staphylococcus aureus; and
               (7)  compile and make available to the public a
  summary[, by location, of the infections reported; and
               [(8)  make recommendations to the department]
  regarding Subdivisions (1) through (6) [(7)].
         (d)  Not later than September 1 of each even-numbered year,
  [2009,] the department, in consultation with each [the] health
  authority participating in [administering] the [pilot] program,
  shall submit to the legislature a report concerning the
  effectiveness of the [pilot] program [in tracking and reducing the
  number of methicillin-resistant Staphylococcus aureus infections
  within the area served by the health authority].
         [(e)     This section expires, and the pilot program is
  abolished, September 1, 2009.]
         SECTION 2.  (a)  Except as provided by Subsection (b) of this
  section, this Act takes effect immediately if it receives a vote of
  two-thirds of all the members elected to each house, as provided by
  Section 39, Article III, Texas Constitution. If this Act does not
  receive the vote necessary for immediate effect, this Act takes
  effect on the 91st day after the last day of the legislative
  session.
         (b)  The change in law made by this Act to Section
  81.0445(d), Health and Safety Code, takes effect September 1, 2009.